Search for: "Sanofi" Results 81 - 100 of 1,186
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 Oct 2010, 10:42 am by By MICHAEL J. DE LA MERCED
Sanofi's chief executive told DealBook that Monday's tender offer for Genzyme shares makes sense, and that absent a firm valuation its $18.5 billion offer won't change. [read post]
31 Aug 2010, 4:30 am by By DEALBOOK
" That, in a nutshell, is the message Chris Viehbacher, the chief executive of Sanofi-Aventis, is sending the management of the biotech company Genzyme in making public his $18.5 billion offer to buy it. [read post]
26 Aug 2010, 7:03 am by Jenna Greene
A federal judge has denied a bid by Sanofi-Aventis to halt sales of a generic version of its blockbuster blood thinner Lovenox, a move which may help pave the way for the Food and Drug Administration to approve generic biologic... [read post]
13 Sep 2010, 4:45 am by By DEALBOOK
Sanofi-Aventis, France's largest drugmaker, arranged about $10 billion of underwritten loans to back its bid for U.S. biotechnology company Genzyme, two people familiar with the situation said. [read post]
10 Feb 2011, 9:22 am by admin
Sanofi lawsuits may shortly be underway since two of its drugs have been linked to seizures and liver damage, resulting in serious personal injury. [read post]
25 Mar 2020, 4:15 am by Joel Wallace
The Sanofi decision provides a possible opportunity to seek antitrust liability against brand companies for abusing Food and Drug Administration (FDA) regulations. [read post]
29 Mar 2023, 9:58 pm by Patent Docs
Sanofi, all three advocates (Jeff Lamken for Amgen, Paul Clement for Sanofi, and Colleen Sindzak for the United States) had reason to reference and discuss an amicus brief submitted on behalf of Nobel Prize-winning scientist Sir Gregory Winter and colleagues,* on the scientific questions raised in the case with regard to what is sufficient to satisfy the enablement requirement of 35 U.S.C. [read post]
16 Dec 2008, 5:16 am
Sanofi-Synthelabo, Sanofi-Synthelabo, Inc., and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership (collectively, Sanofi) brought suit under 35 U.S.C. [read post]
5 Aug 2020, 10:28 am by Muskan Yadav
 Sanofi has maintained that it does not intend to compensate or participate in a state-backed compensation mechanism. [read post]
17 Jul 2017, 7:52 am by Robert Kraft
” The class action “alleges that Sanofi failed to properly inform users about the drug’s potential risks for developing fetuses. [read post]
19 Jun 2007, 9:45 pm
Sanofi and BMS filed the action in March of 2002, contending that... [read post]
15 Apr 2009, 11:37 am
O'Melveny advised BiPar and Sanofi tapped Jones Day for the deal. [read post]
19 Nov 2017, 9:05 pm by Patent Docs
Sanofi that brought clarity to how the Court (and U.S. [read post]
14 Nov 2013, 9:59 pm by Patent Docs
By Donald Zuhn -- Last week, in Sanofi-Aventis v. [read post]